<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28762">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02732301</url>
  </required_header>
  <id_info>
    <org_study_id>188051</org_study_id>
    <nct_id>NCT02732301</nct_id>
  </id_info>
  <brief_title>Postoperative Gastrointestinal Dysfunction After Cardiac Surgery - Occurrence and Search for Biomarkers</brief_title>
  <acronym>GAINDYSFUNCS</acronym>
  <official_title>Gastrointestinal Dysfunktion Efter hjärtkirurgi - förekomst Samt sökande Efter Nya biomarkörer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Örebro County</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the frequency and grade of gastrointestinal
      dysfunction in patients after thoracic cardiovascular surgery, and to search for biomarkers
      of gastrointestinal dysfunction. All adult patients undergoing elective cardiac surgery
      requiring cardiopulmonary bypass at Örebro University Hospital, Örebro, Sweden, are asked
      for participation in this study. All participating patients sign informed consent at the
      inclusion. The first three postoperative days the function of the gastrointestinal tract is
      scored according to a rating scale (grade 0-4), along with other clinical parameters. Plasma
      blood samples are collected from each patient preoperatively and the first three
      postoperative days. The plasma samples are stored in a biobank for later determination of
      plasma proteins. In the analysis, the patients are divided according to the gastrointestinal
      rating scale and the plasma protein expression, gastrointestinal complications and all-cause
      mortality are compared between the groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute gastrointestinal injury score</measure>
    <time_frame>Postoperative days 1-3</time_frame>
    <description>Acute gastrointestinal injury score from Reintam Blaser et al (2012) modified for postoperative patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma protein expression</measure>
    <time_frame>Postoperative days 1-3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal complications</measure>
    <time_frame>30 days postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>30 days postoperative</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Thoracic Surgical Procedures</condition>
  <condition>Gastrointestinal Tract</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <condition>Biomarkers</condition>
  <arm_group>
    <arm_group_label>Elective thoracic cardiovascular surgical patients</arm_group_label>
    <description>Adult patients undergoing elective thoracic cardiovascular surgical procedures requiring cardiopulmonary bypass at Örebro University Hospital, Örebro, Sweden.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiopulmonary bypass</intervention_name>
    <arm_group_label>Elective thoracic cardiovascular surgical patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic cardiovascular surgical procedures</intervention_name>
    <arm_group_label>Elective thoracic cardiovascular surgical patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Four plasma samples, 2 ml each, taken preoperatively and the three first postoperative days,
      which are stored in an approved biobank.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing elective thoracic cardiovascular surgical procedures requiring
        intraoperative cardiopulmonary bypass at Örebro University Hospital, Örebro, Sweden, using
        a consecutive sampling method.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Accepted for an elective thoracic cardiovascular surgical procedure requiring
             cardiopulmonary bypass

          -  &gt;18 years old

        Exclusion Criteria:

          -  Present and severe symptoms from the gastrointestinal tract

          -  Previous major/extensive abdominal surgery

          -  Presence of astomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristofer F Nilsson, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardio-Thoracic and Vascular Surgery, Örebro University Hospital, Örebro, SWEDEN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristofer F Nilsson, MD, PhD</last_name>
    <phone>+46196020352</phone>
    <email>kristofer-bo-ingemar.nilsson@regionorebrolan.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jenny Seilitz, MD</last_name>
    <phone>+46196020357</phone>
    <email>jenny.seilitz@regionorebrolan.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardio-Thoracic and Vascular Surgery, Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Reintam Blaser A, Malbrain ML, Starkopf J, Fruhwald S, Jakob SM, De Waele J, Braun JP, Poeze M, Spies C. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med. 2012 Mar;38(3):384-94. doi: 10.1007/s00134-011-2459-y. Epub 2012 Feb 7.</citation>
    <PMID>22310869</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 4, 2016</lastchanged_date>
  <firstreceived_date>April 4, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
